Cargando…
The impact of adjuvant chemotherapy on survival in mucinous and non-mucinous rectal adenocarcinoma patients after TME surgery
INTRODUCTION: The value of adjuvant chemotherapy for rectal cancer patients is debated and varies in different subgroups. One such subgroup is mucinous adenocarcinoma (MAC), which is more treatment resistant compared to non-mucinous adenocarcinoma (NMAC). To date, mucinous histology is not taken int...
Autores principales: | Vernmark, Karolina, Knutsen, Annika, Loftås, Per, Sun, Xiao-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970087/ https://www.ncbi.nlm.nih.gov/pubmed/36848363 http://dx.doi.org/10.1371/journal.pone.0282211 |
Ejemplares similares
-
Mucinous and Non-Mucinous Rectal Adenocarcinoma—Differences in Treatment Response to Preoperative Radiotherapy
por: Vernmark, Karolina, et al.
Publicado: (2020) -
From palliative to curative treatment - stage IV mucinous adenocarcinoma, successfully treated with metronomic capecitabine in combination with Bevacizumab and surgery- a case report
por: Vernmark, Karolina, et al.
Publicado: (2015) -
Postoperative survival of pulmonary invasive mucinous adenocarcinoma versus non-mucinous invasive adenocarcinoma
por: Cui, Dongyu, et al.
Publicado: (2023) -
Prognosis and Sensitivity of Adjuvant Chemotherapy in Mucinous Colorectal Adenocarcinoma without Distant Metastasis
por: Bong, Jun-Woo, et al.
Publicado: (2022) -
Typical CT and MRI Features of Mucinous Rectal Adenocarcinoma
por: Ryoo, Jin-A, et al.
Publicado: (2019)